Figure 1
Ventilatory efficiency in healthy athletes vs. individuals with hypertrophic cardiomyopathy. Parameters of ventilatory efficiency measured as (A) V˙E/V˙CO2-early slope (through VT), (B) V˙E/V˙CO2-nadir, (C) V˙E/V˙CO2-total slope and (D) PETCO2 at ventilatory threshold in individuals with hypertrophic cardiomyopathy vs. athletes. Horizontal solid lines indicate mean and standard deviation. For (A–C), the interrupted and dotted lines indicate the guideline-recommended V˙E/V˙CO2 cut-off of 30 and the prognostically useful threshold of 34, respectively.10,13,23

Ventilatory efficiency in healthy athletes vs. individuals with hypertrophic cardiomyopathy. Parameters of ventilatory efficiency measured as (A) V˙E/V˙CO2-early slope (through VT), (B) V˙E/V˙CO2-nadir, (C) V˙E/V˙CO2-total slope and (D) PETCO2 at ventilatory threshold in individuals with hypertrophic cardiomyopathy vs. athletes. Horizontal solid lines indicate mean and standard deviation. For (A–C), the interrupted and dotted lines indicate the guideline-recommended V˙E/V˙CO2 cut-off of 30 and the prognostically useful threshold of 34, respectively.10,13,23

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close